The drug tocilizumab, which is used in the treatment of various forms of arthritis, can greatly shorten the time on ventilation and shorten hospital stays for patients with severe COVID-19, a new study from Karolinska Institutet and Karolinska University Hospital published in The Journal of Internal Medicine reports. “The report is, as far as we […]
Listening to Mozart isn’t just an enjoyable diversion, it might also improve health. In a remarkable study, researchers claim that epileptic patients listening to the Austrian composer are prone to fewer seizures than those who don’t. Epilepsy, the most common neurological disorder, affects approximately 50 million people on Earth, according to the World Health Organization. […]
A large team of researchers with members affiliated with a host of institutions in France has identified what they believe is a hallmark of severe COVID-19 patients. In their paper published in the journal Science, the group describes their study of 50 COVID-19 patients in France and what they learned from them. The global pandemic […]
While immunotherapy—a form of treatment that uses the body’s immune system to recognize, attack and kill tumor cells—has given hope to people across the globe, it fails in a significant proportion of cancer patients. However, a new study published in the Nature journal Cell Death Discovery on Monday, July 6, suggests that blocking the tumor-promoting […]
(HealthDay)—Even after undergoing the artery-clearing procedure angioplasty, Black patients with heart disease are more likely than whites to suffer a heart attack or die within the next several years. That’s the conclusion of a new analysis of 10 clinical trials: On balance, both Black and Hispanic patients fared worse after angioplasty, versus white patients. And […]
(HealthDay)—Presentation patterns are similar in patients with type 1 diabetes admitted with confirmed or suspected COVID-19, according to a study published online June 5 in Diabetes Care. Osagie A. Ebekozien, M.D., M.P.H., from the T1D Exchange in Boston, and colleagues assessed patient characteristics and adverse outcomes among patients with type 1 diabetes with confirmed COVID-19. […]
“A new study of researchers at IMT School for Advanced Study Lucca demonstrates for the first time that the slow waves of NREM-sleep travel and propagate in the brain through ‘anatomical highways.’ The scientists have investigated in particular the role of the corpus callosum, the bundle of nervous fibers that connects the two brain emispheres, […]
During the COVID-19 pandemic, patients with multiple sclerosis (MS) and their clinicians have had questions and concerns about whether immunotherapies for MS could influence risk for infection or lead to an unfavorable outcome. In the Journal of Neurology, Rohit Bakshi, MD, a senior neurologist at Brigham and Women’s Hospital, and international co-authors present the cases […]
Giving coronavirus patients remdesivir early may prevent deadly lung damage, suggests study that showed it blocked respiratory disease in monkeys Giving six macaque monkeys infected with coronavirus remdesivir early prevented severe lung disease responsible for many COVID-19 deaths The six that got the treatment showed no signs of lung disease but those that did not […]
Hospitalized COVID-19 patients at a New York City medical facility had higher rates of kidney complications than other COVID-19 patient groups in different areas of the U.S. and other countries, according to a new study from researchers at Columbia University Irving Medical Center and NewYork-Presbyterian. The study, using data from electronic health records and published […]
